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Background
International guidelines are in place for the management
of severe food anaphylaxis. Their implementation in
emergency services is examined to identify the points
needing improvement.
Methods
One hundred and fifty-two cases of severe anaphylaxis
were reported to the Allergy Vigilance Network in
France and Belgium in 2011. Information was recorded
on a standardised form. A thorough analysis was then
undertaken.
Results
78 paediatric and 74 adult cases were reported. Two
deaths occurred. Personnel and emergency centres
involved in the management were known in 147 cases,
and treatment in 136 cases. First-aid was provided at
home by patients themselves on 43 occasions or by the
family physician 12 times. 49 called for an ambulance. 89
required hospitalisation in an Emergency Department.
Epinephrine auto-injectors were used by 4 patients only.
Medicalized ambulances treated 23 patients, and used
epinephrine in 11/23 cases. Emergency departments
treated 58 patients and used epinephrine in 19 cases.
When epinephrine had been injected before arriving at
the ED, no further injection in hospital was necessary. In
total, epinephrine was given to 37 patients (27.2%). The
observation period was much shorter than recommended
in the Directives. Patients were discharged without care
summaries. Allergists implemented school management
plans for all children. 68 to 80% of patients were pre-
scribed self-injectable epinephrine.
Conclusion
Personal care plans including patient education on the
use of epinephrine should be more widely used. The fre-
quent prescription of self-injectable epinephrine to the
patients is almost at no use. As patients fail to use them
when necessary, paramedics should be equipped with
auto-injectors and trained to identify severe symptoms.
We recommend improved coordination between emer-
gency doctors, paediatricians and allergists.
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Table 1 Clinical features of severe food anaphylaxis treated by epinephrine.






% treatment by epinephrine
37 cases
Anaphylactic shock 8.9 24.2 16.4 54.2
Systemic reaction 66,6 51.3 59.2 16.3
Acute asthma 2.6 5.4 3.9 66.7
Laryngeal angioedema 11.5 12.2 11.8 16.7
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